At the Opocrin Group, we remain true to our roots, continuing to innovate thanks to a dynamic approach that is open to all things new.
In recent years, the Group’s great expansion has been accompanied by a strong increase in the workforce and by investments to improve and innovate skill sets with a view to continuing professional and individual development.
Our People
Each new success achieved at Opocrin is the result of the energy, dedication and curiosity of everyone who works there. It is thanks to them that we are able to produce new and increasingly safe therapeutic solutions.
We invest with conviction in a number of continuing education, skill set development and resource management programmes. To grow together.
Meet the Board
President
Mara Bianchini
“We strongly believe in continuity: to grow and expand in the global market we maintain the same spirit and the same propensity to innovation”
CEO, Vice-President
Federico Saetti
“At Opocrin, we act as a single body, looking in the same direction and growing together, every day”
Chief R&D and quality officer
Enrica Bovina
“An innovation-oriented approach: we strive to demonstrate new opportunities for the development and use of heparin and its derivatives. And open up new therapeutic options.”